ESMO World Congress on Gastrointestinal Cancer 2017

Oncology Meeting Resources

28 Jun - 01 Jul 2017, Barcelona, Spain

ESMO World GI 2017 square image

The ESMO World Congress on Gastrointestinal Cancer 2017 (World GI) is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumours.

Abstracts, presentations and webcasts are open access. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Watch the ESMO scientific videos

Best Abstracts Session on Colorectal Cancer, Speaker: Filippo Pietrantonio

Tips for Practice: MSI Testing in GI Cancers, Speaker: Fatima Carneiro

Prevention of Colorectal Cancer, Speaker: Nadir Arber

The Role of Microbiome in Cancer Medicine, Speaker: James Godaert

All interviews from the event on the ESMO Channel





Format available

https://oncologypro.esmo.org/Meeting-Resour...atients-with-gastric-cancer-Can-we-do-better

The effects of preoperative malnutrition and PCH on the short- and long-term outcomes in patients with gastric cancer are unclear.

Date: 28 Jun 2017
Presenter: Jun Lu
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...-cancer-HGCSG1401-Analysis-of-tumor-location

Recent analysis from some clinical trials showed that primary tumor location in patients with metastatic colorectal cancer (mCRC) correlates with different outcome.

Date: 28 Jun 2017
Presenter: Yoshito Komatsu
Resources: Abstract
Topics: Gastrointestinal Cancers, Colon Cancer, Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...er-with-enlarged-suprapancreatic-lymph-nodes

This study compared oncologic efficacy of laparoscopic radical gastrectomy (LAG) with open gastrectomy (OG) for gastric cancer with preoperative enlarged lymph nodes (ELNs).

Date: 28 Jun 2017
Presenter: Qi-Yue Chen
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...elet-ratio-RPR-in-advanced-colorectal-cancer

Colorectal cancer (CRC) is one of the most common and leading cause of cancer deaths worldwide. In recent years, many new prognostic markers such as neutrophil to lymphocyte ratio and lymphocyte to...

Date: 28 Jun 2017
Presenter: Gökçen Çevik
Resources: Abstract
Topics: Gastrointestinal Cancers, Colon Cancer, Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...is-of-the-American-Joint-Committee-on-Cancer

The purpose of this study is to explore the value of the seventh edition of AJCC staging and improved AJCC staging in the evaluation of the prognosis of gastric neuroendocrine carcinoma (GNEC).

Date: 28 Jun 2017
Presenter: Jian-Wei Xie
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...arge-scale-single-centre-retrospective-study

The prognostic prediction for long-term survival for patients of proximal gastric cancer has not been well established.

Date: 28 Jun 2017
Presenter: Qi-Yue Chen
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...afety-and-efficacy-in-a-real-life-population

A III-phase clinical trial has demonstrated benefit in global survival using aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer (mCRC) who progressed after being...

Date: 28 Jun 2017
Presenter: Beatriz González-Astorga
Resources: Abstract
Topics: Gastrointestinal Cancers, Colon Cancer, Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...I-and-III-esophagogastric-junction-carcinoma

The aim of this study was to clarify the optimal abdominal lymphadenectomy for advanced in Siewert types II and III adenocarcinoma of the esophagogastric junction (AEG).

Date: 28 Jun 2017
Presenter: Jianxian Lin
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...age-therapy-for-metastatic-colorectal-cancer

Raltitrexed is used as an alternative to fluoropyrimidines (FP) for the treatment of colorectal cancer patients. Here, we retrospectively evaluate the toxicity and efficacy of raltitrexed as salvage...

Date: 28 Jun 2017
Presenter: Juan Luis Torres-Tenor
Resources: Abstract
Topics: Gastrointestinal Cancers, Colon Cancer, Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...ients-with-metastatic-colorectal-cancer-mCRC

For patients with mCRC and disease progression after the available standard cytotoxic and biologic agents, treatment options outside the context of a clinical trial are limited.

Date: 28 Jun 2017
Presenter: Nemanja Stanic
Resources: Abstract
Topics: Gastrointestinal Cancers, Colon Cancer, Rectal Cancer